Early molecular response with Imatinib therapy in chronic Myeloid Leukemia and its association with baseline white blood cell count and Spleen size
PAFMJ-Pakistan Armed Forces Medical Journal. 2018; 68 (5): 1199-1204
en Inglés
| IMEMR
| ID: emr-206445
ABSTRACT
Objectives:
To determine the frequency of early molecular response in patients of chronic myeloid leukemia treated with Imatinib and its association with baseline white blood cell [WBC] count and spleen size
Buscar en Google
Índice:
IMEMR (Mediterraneo Oriental)
Idioma:
Inglés
Revista:
Pak. Armed Forces Med. J.
Año:
2018
Similares
MEDLINE
...
LILACS
LIS